Derek Chalmers
2019
In 2019, Derek Chalmers earned a total compensation of $3.4M as President and Chief Executive Officer at Cara Therapeutics, a 23% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $310,800 |
|---|---|
| Option Awards | $2,551,783 |
| Salary | $560,000 |
| Other | $11,034 |
| Total | $3,433,617 |
Chalmers received $2.6M in option awards, accounting for 74% of the total pay in 2019.
Chalmers also received $310.8K in non-equity incentive plan, $560K in salary and $11K in other compensation.
Rankings
In 2019, Derek Chalmers' compensation ranked 3,556th out of 13,971 executives tracked by ExecPay. In other words, Chalmers earned more than 74.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,556 out of 13,971 | 75th |
Division Manufacturing | 1,284 out of 5,701 | 78th |
Major group Chemicals And Allied Products | 446 out of 2,200 | 80th |
Industry group Drugs | 373 out of 1,886 | 80th |
Industry Pharmaceutical Preparations | 282 out of 1,398 | 80th |
Source: SEC filing on April 22, 2020.
Chalmers' colleagues
We found three more compensation records of executives who worked with Derek Chalmers at Cara Therapeutics in 2019.
News
Cara Therapeutics CEO Derek Chalmers' 2021 pay jumps 250% to $10M
April 22, 2022
Cara Therapeutics CEO Derek Chalmers' 2020 pay slips 15% to $2.9M
April 23, 2021
Cara Therapeutics CEO Derek Chalmers' 2019 pay jumps 23% to $3.4M
April 22, 2020
Cara Therapeutics Chief Medical Officer Joana Goncalves receives $3.7M in 2018
April 24, 2019